looks moving down if we break the 2590
Will Hikma break out after a 5 year H&S pattern, now that it's making progress in the Covid-19 vaccine business?
Buy Hikma Pharmaceuticals (HIK.L) Hikma Pharmaceuticals PLC develops, manufactures, and markets pharmaceutical products. The Company offers branded and non-branded generic and in-licensed pharmaceutical products. Hikma Pharmaceuticals serves customers worldwide. Market Cap: £4.79Billion The long-term trend on Hikma remains bullish. The corrective move lower...
looking for trend to continue long term
Co. receive good news
